At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pulmonary Hypertension--Mechanisms and Family Registry
In Brief
An observational study for Lung Diseases and Hypertension, Pulmonary. Completed.
Detailed Summary
To establish a registry of primary pulmonary hypertension (PPH), a lethal disease which causes progressive obstruction of small pulmonary arteries and to investigate basic mechanisms of the disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases, Hypertension, Pulmonary
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 1994
Primary CompletionMar 1999
First PostedMay 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartApr 1, 1994
Primary CompletionMar 1, 1999
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 26.1 years ago